Healthcare & Life Sciences
LB Pharmaceuticals
New York, United Stateslbpharma.us
LB Pharmaceuticals is a series a startup based in United States. Status: dead.
Defunctseries-c-plus
series-c-plus
Stage
2
Investors
About LB Pharmaceuticals
LB Pharmaceuticals is a company headquartered in New York, the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
LB Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases, including schizophrenia. Its lead product candidate is LB-102, an oral small molecule.
Explore LB Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.